ContraFect Corporation ContraFect Corporation Nasdaq: CFRX

Navigate ContraFect Corporation

  • Home
  • About Us
    • Overview
    • Management Team
    • Board of Directors
  • Technology
    • Overview
    • Lysins
    • Amurins
    • Publications / Posters
    • Video Library
  • Pipeline
    • Overview
    • Exebacase
    • CF-370
    • Gram-negative Lysins
    • Amurins
  • Investors & Media
    • Overview
    • News / Events
    • Presentations
    • Company Information
    • Financial Information
    • Analyst Coverage
    • Stock Data
    • SEC Filings
    • Corporate Governance
  • Careers
  • Contact Us

Press Releases

Investors & Media

  • Home
  • Investors & Media
  • News / Events
  • Press Releases
Investors & Media

Investors & Media

  • Overview
  • News / Events
    • Press Releases
    • Media Coverage
    • Events
    • Email Alerts
  • Presentations
  • Company Information
  • Financial Information
  • Analyst Coverage
  • Stock Data
  • SEC Filings
  • Corporate Governance
  • Email Alerts
  • Tear Sheet
  • Contacts
  • RSS News Feed
  • All News
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010

ContraFect Announces Appointment of Lishan Aklog, M.D. to Board of Directors

June 15, 2020

ContraFect Corporation Announces Private Placement of Common Stock and Warrants to Pfizer Inc.

May 26, 2020

ContraFect Corporation Prices Approximately $52.5 Million Public Offering of Common Stock and Warrants

May 21, 2020

ContraFect Corporation Announces Proposed Public Offering of Common Stock and Warrants

May 21, 2020

ContraFect Reports First Quarter 2020 Financial Results and Provides Business Update

May 15, 2020

ContraFect Announces Four Abstracts Published in the 30th ECCMID Abstract Book

May 11, 2020

ContraFect Announces Dr. Roger J. Pomerantz, Chief Executive Officer and Chairman, Invited as Keynote Speaker and Presenter in Maxim’s Infectious Disease Virtual Conference

April 21, 2020

ContraFect to Chair and Participate in Virtual Superbugs & Superdrugs 2020 Conference

March 30, 2020

ContraFect Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Business Update

March 18, 2020

ContraFect to Present at FDA Workshop on Advancing Animal Models for Antibacterial Drug Development

March 4, 2020

RSS
  • « Previous
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • ...23
  • Next »
© 2023 ContraFect Corporation. All Rights Reserved.
Copyright Privacy Policy Expanded Access Policy Disclaimer Site Map
LinkedIn Twitter